Chongqing Huasen Pharmaceutical Co., Ltd. (stock abbreviation: Huasen Pharmaceutical, stock code: 002907) is a national key high-tech enterprise integrating drug research and development, production and sales, and an A-share listed company in Shenzhen Stock Exchange. Over the years, the company has successively won the National Enterprise Technology Center, the National Advanced Private Enterprise for Employment and Social Security, the Healthy China Quality Award, the Chinese Patent Award, the top 100 Chinese OTC enterprises in 2019, the pharmaceutical industry benchmark enterprise for the 70th anniversary of the founding of New China, the national contract abiding and trustworthy enterprise, the national intellectual property rights demonstration enterprise, and the top 100 ranking list of Chinese traditional medicine enterprises in 2019 In 2020, China's pharmaceutical industry will be the most growing enterprise, Chongqing's advanced grass-roots party organization and other honors, and post doctoral research workstation and Chongqing Haizhi workstation will be set up. Huasen Pharmaceutical consists of Chongqing Huasen Biotechnology Co., Ltd., Chongqing Huasen Pharmaceutical Co., Ltd., Chongqing Huasen Pharmacy Retail Chain Co., Ltd. and Pharscin US Inc. Huasen Pharmaceutical (America) Co., Ltd.
In line with the concept of "science and technology leading, innovation driving, essence inheritance, integrity and innovation", Huasen Pharmaceutical has created high-quality products that are "specialized, refined, special and new". At present, the company has 70 drug approval numbers, including Chinese patent medicines, chemical raw materials and preparations, including 51 drugs listed in the national "medical insurance" catalogue, 46 national drug standards, 67 patents, and has undertaken 120 scientific and technological research and development projects of national, provincial and municipal ministries.
Huasen Pharmaceutical is actively laying out the innovative medicine track, introducing world-class scientists, establishing an innovative medicine business department, and building an overall R&D capability of innovative medicine. At present, it has four self-developed innovative tumor medicine research projects, with potential indications covering tumor immunity, lung cancer, breast cancer, colorectal cancer, pancreatic cancer and other solid tumors. The company has built three innovative drug platforms with international level, namely "molecular targeted drug bioactivity screening platform based on functional genomics for different types of targets", "small molecule drug structure design and synthesis platform for specific targets" and "drug metabolism and pharmacokinetics testing platform for drug performance evaluation", Have the ability to research and develop innovative drugs from drug discovery to preclinical development, and achieve the breakthrough of innovative drugs from 0 to 1.
In terms of external cooperation of innovative drugs, Chengdu Aorui Pharmaceutical Co., Ltd., a new drug research and development company based on artificial intelligence drug discovery technology platform dedicated to small molecule targeted innovative drugs, was established through cooperation with the scientific research achievements transformation platform of the national key laboratory of biological therapy of Sichuan University; Cooperate with Western Research Institute of Chinese Science Computing Technology and Beijing Zheyuan Technology Co., Ltd. to screen new tumor drug targets, develop candidate drugs, research on translational medicine, preclinical and clinical development, registration application, market access and other work, and create a new height of biomedical innovation.
In Rongchang High tech Zone, Huasen Pharmaceutical has built an international first-class drug production platform integrating the Internet, big data and artificial intelligence. It has 22 production lines for tablets, soft capsules, freeze-dried powder injections, API synthesis, and pretreatment and extraction of traditional Chinese medicine. It has also built a fully automatic intelligent production line for Chinese medicine extraction and a modern warehousing and logistics center. It has fully implemented MES BMS, EMS, SCADA, DCS and other artificial intelligence systems are passing the FDA certification in the United States, and it is planned to build an international drug CDMO production platform. It has been awarded the titles of National Intelligent Manufacturing Demonstration Factory, Network Security Classification and Hierarchical Management Pilot Enterprise of the Ministry of Industry and Information Technology of the People's Republic of China, Chongqing Top Ten 5G Industrial Internet Pilot Demonstration Enterprise, etc.
Watson Pharmaceutical has always adhered to the promotion of professional chemistry to convey leading, accurate and up-to-date information and services to the majority of medical workers. At present, the academic network has covered 31 provinces, municipalities and autonomous regions in China. At the same time, Pharscin US Inc. was established in the United States to help the company find cooperation goals in the frontier of innovative drugs in Europe and the United States.
Huasen Pharmaceutical actively fulfills its social responsibilities, adopts the model of "company research institute farmers", establishes standardized planting bases of Chinese medicinal materials in Rongchang, Xiushan, Wanzhou and other places in Chongqing, participates in targeted poverty alleviation, and drives local farmers to increase income and become rich; The company donated more than 2 million yuan of drugs and medical protective materials to the front lines of epidemic areas such as Wuhan; 512 Wenchuan earthquake relief, 4.20 Ya'an earthquake... Every public welfare site is full of Huasen people. It has successively won the honors of "love unit", advanced private enterprise in Chongqing to fight against COVID-19, and advanced private enterprise in the targeted poverty alleviation action of "10000 enterprises helping 10000 villages".
Huasen Pharmaceutical regards talents as the first resource for enterprise development, and always adheres to the talent strategy of "people first, employees achievement", carries out all-round training for employees, and introduces a number of welfare insurance systems to provide employees with space for sustainable development. At the same time, the company focuses on creating a corporate culture atmosphere of "Watson is my home", improving the sense of belonging and initiative of employees, and achieving employee happiness.
Huasen Pharmaceutical takes "developing good medicine, healthy human beings, and achieving employees" as its corporate mission, adheres to the values of "integrity, diligence, gratitude, learning, teamwork, and innovation", and strives for the Huasen Dream of "becoming an international first-class pharmaceutical enterprise, making the world free from incurable diseases" with a solid pace, contributing to the construction of Chengdu Chongqing double city economic circle, To contribute to the realization of the Chinese Dream of the great rejuvenation of the Chinese nation.
